IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1

Clinical trial NCT01732796 · COMPLETED

Trial details

NCT number: NCT01732796
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2012-12-01
Primary completion: 2015-01-01
Enrollment: 470

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.